Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
Authors
Keywords
Hepatocellular carcinoma, Portal vein tumour thrombus, Interventional therapy, Brachytherapy, Survival
Journal
EUROPEAN RADIOLOGY
Volume 26, Issue 10, Pages 3428-3436
Publisher
Springer Nature
Online
2016-01-21
DOI
10.1007/s00330-015-4198-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
- (2015) Timm Denecke et al. EUROPEAN RADIOLOGY
- Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study
- (2014) Kangshun Zhu et al. RADIOLOGY
- Treatment of hepatocellular carcinoma in Child-Pugh B patients
- (2013) Fabio Piscaglia et al. DIGESTIVE AND LIVER DISEASE
- Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial
- (2013) MinJie Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma
- (2013) Alina Lintia-Gaultier et al. NUCLEAR MEDICINE COMMUNICATIONS
- Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study
- (2013) Qing-he Tang et al. WORLD JOURNAL OF SURGERY
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
- (2012) Matthias Pinter et al. RADIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
- (2011) Bruno Sangro et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes
- (2011) Sang Min Yoon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TACE and Sorafenib: A Good Marriage?
- (2011) Ghassan K. Abou-Alfa JOURNAL OF CLINICAL ONCOLOGY
- Radioembolization for hepatocellular carcinoma
- (2011) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
- (2010) Jie Shi et al. ANNALS OF SURGICAL ONCOLOGY
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
- (2010) Jun Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma
- (2010) Brian I. Carr et al. CANCER
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
- (2009) Giuseppe Cabibbo et al. HEPATOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started